Finland · Delayed Price · Currency is EUR Nexstim Company Description
Nexstim Plc, a medical technology company, engages in the development of non-invasive brain stimulation technologies in Finland, rest of Europe, North America, and internationally.
The company offers non-invasive brain stimulation technology for navigated transcranial magnetic stimulation (nTMS), including Navigated Brain Stimulation (NBS) system 6 for presurgical mapping of the speech and motor cortices of the brain, for the treatment of major depression and chronic unilateral neuropathic pain, and post-operative rehabilitation of motor deficits of the upper limb.
The company markets and sells its diagnostics systems to universities and teaching hospitals. It has an exclusive collaboration with Sinaptica Therapeutics, Inc. for the development, manufacture, and delivery of precision neuromodulation system for the treatment of Alzheimer’s disease and mild cognitive impairment; and a development and distribution collaboration with Brainlab AG for motor and speech mapping systems.
The company was incorporated in 2000 and is headquartered in Helsinki, Finland.
| Country | Finland |
| Founded | 2000 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 40 |
| CEO | Mikko Karvinen |
Contact Details
Address: Elimäenkatu 9 B Helsinki, 00510 Finland | |
| Phone | 358 9272 7170 |
| Website | nexstim.com |
Stock Details
| Ticker Symbol | NXTMH |
| Exchange | Nasdaq Helsinki |
| Fiscal Year | January - December |
| Reporting Currency | EUR |
| ISIN Number | FI4000506811 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Mikko Karvinen | Chief Executive Officer |
| Joonas Juokslahti | Chief Financial Officer |
| Henri Hannula | Chief Commercial Officer |